Subscribe To
Kprx stock: 38.7% surge explanation
The stock price of Kiora pharmaceuticals, Inc. (NASDAQ: KPRX) surged by 38.7% in the most recent tradin...
February 8, 2023, 2:39 am
Isoray inc. and viewpoint molecular targeting inc. announce name change to perspective therapeutics inc.
Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and...
February 7, 2023, 10:48 pm
Enanta pharmaceuticals, inc. (enta) q1 2023 earnings call transcript
Enanta pharmaceuticals, Inc. (NASDAQ:ENTA ) Q1 2023 Earnings Conference Call February 7, 2023 4:30 PM E...
February 7, 2023, 10:12 pm
Vertex pharmaceuticals incorporated (vrtx) q4 2022 earnings call transcript
Vertex pharmaceuticals Incorporated (NASDAQ:VRTX ) Q4 2022 Earnings Conference Call February 7, 2023 4:...
February 7, 2023, 9:10 pm
Vertex pharmaceuticals (vrtx) q4 earnings and revenues beat estimates
Vertex (VRTX) delivered earnings and revenue surprises of 6.52% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clue...
February 7, 2023, 6:49 pm
Enanta pharmaceuticals (enta) reports q1 loss, tops revenue estimates
Enanta pharmaceuticals (ENTA) delivered earnings and revenue surprises of 8.55% and 2.32%, respectively...
February 7, 2023, 6:49 pm
Vertex offers upbeat guidance after beating fourth-quarter profit views
Vertex pharmaceuticals offered an upbeat look for 2023 sales after reporting an earnings beat and in-li...
February 7, 2023, 4:11 pm
Deciphera pharmaceuticals, inc. (dcph) q4 2022 earnings call transcript
Deciphera pharmaceuticals, Inc. (NASDAQ:DCPH ) Q4 2022 Earnings Conference Call February 7, 2023 8:00 A...
February 7, 2023, 1:50 pm
What makes kalvista pharmaceuticals, inc. (kalv) a new buy stock
KalVista pharmaceuticals, Inc. (KALV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing op...
February 7, 2023, 1:33 pm
Outlook therapeutics® to present at the svb securities global biopharma conference
– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET – ISELIN, N.J., F...
February 7, 2023, 1:05 pm
Catalyst pharmaceuticals reports preliminary fourth quarter and full year 2022 total revenues and provides full year 2023 revenue guidance
2022 Total Revenues Estimated at $214 Million, Representing 52% YoY Growth Forecast 2023 Total Revenues of Between $375 Million and $385 Million Inclu...
February 7, 2023, 1:03 pm
Rising pharma prices could give a beat to hart etf
Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some ...
February 7, 2023, 12:41 pm
Empower clinics partners with nuclear medicine specialist to launch us clinical trial management services
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has entered into a letter of intent (LOI) with Dr Bharat Mocherla, a Nuclear Medicine Specialist i...
February 7, 2023, 9:54 am
Deciphera pharmaceuticals, inc. (dcph) reports q4 loss, tops revenue estimates
Deciphera pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of -5.26% and 2.59%, re...
February 7, 2023, 9:47 am
Avicanna expands partnership with viola brands to commercialize its products in uk
Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) announced that it has entered into a new sub-license agreement with VB Brands California LLC (Viola Brands) and P...
February 7, 2023, 9:34 am
Why is kiora pharmaceuticals (kprx) stock up 61% today?
Kiora pharmaceuticals (NASDAQ: KPRX ) stock is heading higher on Tuesday thanks to an update on its KIO...
February 7, 2023, 9:21 am
Is biotech immunocore about to make a 25% price move?
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron ...
February 7, 2023, 7:00 am
Atea pharmaceuticals to present at the svb securities global biopharma conference
BOSTON, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Atea pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a cli...
February 7, 2023, 7:00 am
Idorsia announces financial results for 2022 – building momentum to become a leading mid-sized biopharmaceutical company
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – 7, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for 2022. ...
February 7, 2023, 6:29 am
Macrogenics to participate in upcoming investor conferences
ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical...
February 6, 2023, 9:30 pm